RECRUITING

Bright Light Exposure in Critical Ill Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

1. Elucidate the influence of intense light therapy pretreatment in patients undergoing cardiac surgery. We hypothesize that intense light exposure is associated with the peripheral stabilization of Per2 in human buccal swabs and plasma samples before surgery and with a decrease of Troponin I levels after surgery. In addition, we hypothesize that light therapy leads to Per2 dependent metabolic optimization in the human cardiac tissue. Therefore, a small piece of human heart tissue from the right atrium will be collected during cardiac cannulation, which will be otherwise discarded. 2. Critical illness (being in the intensive care unit) results in circadian malfunction and vessels not working. Vessel function is controlled by the body's circadian clock. Intense light boosts the circadian clock and the vessel function in animal studies. Vessels not working well in critical ill patients results in a myriad of severe diseases (delirium, stroke, heart attack, organ damage etc). Thus we will test if intense light can be used to boost the circadian clock and the associated vessel function in critical ill patients.

Official Title

Bright Light Exposure in Critical Ill Patients and Patients Undergoing Cardiac Surgery

Quick Facts

Study Start:2019-07-12
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03822949

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients undergoing primary sternotomy cardiac surgery
  2. * Subjects in the range of 18 - 90 years old .
  3. * Patient need to be in sinus rhythm at the time of surgery.
  1. * patients \<18 or \>90 years old
  2. * participation in other clinical trials within the previous 30 days
  3. * pregnancy
  4. * neurological conditions that could impair weaning from ventilator support
  5. * significant CNS disorders or comorbid irreversible conditions with a six-month mortality rate more than 50 percent
  6. * prisoners, or subjects with altered capabilities to make decision will be enrolled
  7. * medical history of type 2 diabetes
  8. * patients with atrial fibrillation or use of class III anti-arhythmic drug
  9. * patients with a left ventricle ejection fraction \< 40%
  10. * patient in emergency condition

Contacts and Locations

Study Contact

Tobias Eckle, MD, PhD
CONTACT
7209495646
tobias.eckle@cuanschutz.edu
Nick Naughton, BS
CONTACT
303-724-0833
NICK.NAUGHTON@CUANSCHUTZ.EDU

Principal Investigator

Tobias Eckle, MD, PhD
PRINCIPAL_INVESTIGATOR
UC Denver

Study Locations (Sites)

University of Colorado Denver | Anschutz Medical Campus
Denver, Colorado, 80220-3706
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Tobias Eckle, MD, PhD, PRINCIPAL_INVESTIGATOR, UC Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-07-12
Study Completion Date2025-07

Study Record Updates

Study Start Date2019-07-12
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Myocardial Ischemia
  • Critical Illness
  • Endothelial Dysfunction